Showing 1051-1060 of 3135 results for "".
Providing the Best Outcomes with Dermal Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/glaser/18972/What can we look forward to in the way of fillers in the year ahead? According to Dee Anna Glaser, MD, there may be several new tools in your tool chest, but in the end, it's how they're utilized that's most important. Dr. Glaser, Vice Chairman, Dept. of Dermatology, St. Louis University School of"Ask Me Anything" Mentorship Session With Dr. Sheila Barbarino
https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-with-dr-sheila-barbarino/39880/Sheila Barbarino, MD, FACS, discusses the keys to her success using social media as a marketing tool for her practice, critical practice management issues, and more. YoungMD Connect is an editorially independent platform made possible by industry sponsorships. We would like to thank our gold platfThe Battle of Biostimulators: PLLA vs Hyperdilute CaHA
https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/the-battle-of-biostimulators-plla-vs-hyperdilute-caha/39250/Modern Aesthetics executive editor Kay Durairaj, MD, FACS, hosts a workshop describing the differences between two dermal filler options, and how she utilizes both in her practice. YoungMD Connect is an editorially independent platform made possible by industry sponsorships. We would like to thank oDWTV Extra: Rocatinlimab Trials
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-rocatinlimab-trials/39044/Clinical investigator Emma Guttman-Yassky, MD, PhD, discusses two sets of data presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025. The phase 3 ROCKET-Ignite Trial evaluated the efficacy and safety of OX40-receptor targeting with rocatinlimab in moderate-to-severe aCombatting Disparities in Dermatology
https://practicaldermatology.com/topics/general-topics/combatting-disparities-in-dermatology/18338/Research shows disparities in dermatology exisit. Junko Takeshita, MD, PhD, MSCE discusses some examples, such as racial disaparities in which patients recieve biolgics to treat severe psoriasis. She also shares tips on how to determine what implicit biases you may have to race, gender, weight, etc.Dr. Joel Schlessinger discusses Botox treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-joel-schlessinger-discusses-botox-treatments/19321/Joel Schlessinger, MD takes you through a BOTOX treatment step-by-step, explaining each piece of the process. The video begins with a quick description of BOTOX, Dysport and Xeomin before moving on to show the process of taking pre-treatment photos and performing a consultation. Dr. Schlessinger theCurrents: Cosmetic Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-cosmetic-dermatology/23463/Currents
https://practicaldermatology.com/topics/practice-management/currents-7/23346/GLP-1RAs and the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1ras-and-the-dermatologist/48885/We are only beginning to understand the implications of GLP-1s for skin and systemic health. These medications are here to stay, and dermatology must be part of the conversation.Of Pandemics and Postponements
https://practicaldermatology.com/topics/practice-management/of-pandemics-and-postponements/23342/